Source: www.nationnews.com
Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Christ Church, Barbados
Updated:
Source: www.nationnews.com
Seven employees tested positive for Covid-19, Kooyman Megastore Barbados, Oistins, Barbados
3 years ago
Source: www.nationnews.com | Symptoms: Gas
Recent Interesting Reports
Subgenix, Atlanta, GA, USA
4 weeks ago •reported by user-dmdh4166
Scam Keto-genesis keto+Acv, Las Vegas, NV, USA
2 weeks ago •reported by user-yqjkt272
Poor product; not as advertised, Burke VA
2 days ago •reported by user-tcjqd122
*Aaron Wang, 3611 S Ashland Ave, Chicago IL 60609
*Deathers Fottys, 3646 S Wolcott Ave, Chicago IL. 60609
I want to return for a refund, but there aren’t any instructions on the return policy. I received two of the
Sent the wrong gummies for the 2nd time. I want my money back, Maple Lake, MN, USA
1 week ago •reported by user-vcbtc819
Mystery boxes, Nürnberg, Deutschland
1 week ago •reported by user-ggxxg818
I received a packet of seeds I didn't order, Industry Cir, Mirada, CA 90638, USA
1 week ago •reported by user-kwwr7591
Scam, Valley Bend, WV, USA
5 days ago •reported by user-nxkzm273
I am reporting a bottle of subgenix, New York, NY 10024, USA
3 weeks ago •reported by user-dfhq9323
AvKARE, LLC Atovaquone Oral Suspension - recalled due to potential Bacillus cereus contamination, USA
3 weeks ago •source www.fda.gov
Recall notice
Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.
The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.
AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024
Source: www.fda.gov
Unordered Package, Alabama, USA
1 week ago •reported by user-qxrht522